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Mild vitamin A deficiency leads to inborn nephron deficit in the
rat.
Background. Vitamin A plays a critical role in fetal organogen-
esis, and its severe deficiency during pregnancy is known to result
in malformations of several organs, including the kidney. How-
ever, the consequences of mild vitamin A deficiency (VAD) has
received little attention. In the present study, we examined the
effect of in utero exposure to mild VAD on renal organogenesis.
Methods. A rat model of mild VAD compatible with normal
gestation was developed. Plasma retinol was determined by
reverse phase HPLC in mothers and fetuses. Nephron counting
was performed in kidneys of fetuses and pups issued from control
and VAD mothers. Metanephroi explanted from 14-day-old fe-
tuses from both groups were cultured in the presence or absence
of retinoic acid (RA), and growth and differentiation were
assessed. c-ret expression was analyzed from fetuses exposed in
utero to VAD or to normal vitamin A status and also in meta-
nephroi grown in culture with or without RA using RT-PCR.
Results. The 50% reduction in circulating vitamin A levels
induced by vitamin A deprivation in pregnant rats did not affect
the overall fetal development. However, the number of nephrons
was reduced by 20% in 21-day-old VAD fetuses. The number of
nephrons was closely correlated with circulating vitamin A level in
both VAD and control fetuses. Metanephroi taken from VAD
fetuses developed to a lesser extent in vitro, but their capacity to
respond to exogenous retinoic acid was not altered. Finally, we
found that the expression of the proto-oncogene c-ret was mod-
ulated according to the retinoid environment.
Conclusion. We conclude that vitamin A supply to the fetus is
critical in determining the number of nephrons. Data available
thus far on the frequency of mild VAD during pregnancy and on
the long-term consequences of inborn nephron deficit highlight
the clinical relevance of the present study.
Vitamin A deficiency (VAD) is a massive public health
problem, mostly in developing countries where it is often
part of complex nutritional deficiencies [1–3]. An insuffi-
cient vitamin A supply for basic needs may also be related
to dietary habits, whatever the caloric intake, and to
noncontrolled weight-reducing diets [1]. Finally, low circu-
lating levels of retinol and RBP have been reported in
patients with liver disease, gastrointestinal disorders or
chronic alcoholism [4–6]. Whatever the origin of vitamin A
deficiency, women of child-bearing age are particularly at
risk because of the extra requirements of this nutrient
during pregnancy and lactation [7, 8]. Due to the essential
role of vitamin A and its metabolites during prenatal
development, vitamin A status is critical for the fetus
[9–12]. This is also the time point in life during that a deficit
is the most likely to occur, since in addition to a possible
vitamin A deficiency in the mother, any reduction in the
placental blood flow, irrespective of the mother’s status,
will reduce the supply of vitamin A to the fetus. It has been
recognized for decades that severe maternal vitamin A
deficiency results in fetal death or major congenital mal-
formations in the offspring [13, 14]. By contrast, the
consequences of mild vitamin A deficiency during preg-
nancy have received little attention because the resulting
newborns are apparently normal [8, 15]. Nevertheless, a
mild vitamin A deficiency may cause clinically silent defects
in organogenesis that are not recognized at birth, but may
induce long-term functional consequences. Since vitamin A
and retinoic acid have recently been reported to be key
determinants in the control of nephron number in rat
metanephric organ cultures [16], the kidney appears as one
of the organs whose development might be impaired by an
insufficient vitamin A supply.
In the current study we examined the renal development
in a rat model of in utero exposure to a mild vitamin A
deficiency, allowing an overall normal development to
occur. We found that a reduction of circulating vitamin A
in the mother induced a nephron deficit in the fetus. The
number of nephrons was strictly correlated to circulating
levels of vitamin A. We also found that expression of the
protooncogene c-ret, which was recently reported to play
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an essential role in renal organogenesis [17], was modu-
lated by retinoid environment, thus indicating that the
control of nephron mass by vitamin A might be partly
mediated by the tyrosine kinase receptor Ret. The clinical
implication of these studies is highlighted by recent obser-
vations that inborn nephron deficit, even a moderate
deficit, represents a potential risk factor for the progression
in patients with chronic renal disease [18–20]. Further-
more, some have also suggested that a reduced number of
nephrons favors the development of hypertension [18].
METHODS
Animals
Female Sprague-Dawley rats aged 30 days (weight
around 100 g) were assigned to two groups. The control
group received the standard chow for pregnant and lactat-
ing rats (19,800 IU/kg vitamin A). Animals of the vitamin
A-deficient group (VAD) were fed the same diet with no
vitamin A (100 6 100 IU/kg). Both diets were purchased
from UAR Laboratory (Villemoison sur Orge, France).
The females were maintained on their respective diets for
three weeks before mating. They were then housed with
males overnight and those having vaginal smears containing
spermatozoids the following day were housed separately;
this day was considered to be day 0 of gestation. The two
diets were maintained until the day of experiment. Body
weight was recorded three times a week.
Experimental design
Six pregnant females of the VAD group and five from
the control group were used on day 21 of gestation. They
were weighed and anesthetized with sodium pentobarbital
(5 mg/100 g body wt), and the fetuses were delivered by
caesarian section. Four fetuses were randomly taken,
weighed, and their blood collected from axillary vessels for
plasma retinol assay. The left kidney was removed, weighed
and prepared for nephron counting. Blood samples were
taken from the mothers before sacrifice for plasma retinol
determination. In three other females of each group,
fetuses were used on day 15 of gestation and metanephroi
collected for analysis of c-ret expression. Eight pregnant
females of each group were allowed to deliver spontane-
ously, and the pups weighed four hours later. The litters
were reduced to eight pups taken at random. All the pups
were weighed on postnatal days 7 and 14. Four pups were
randomly taken from each litter on day 14 and used for
plasma retinol determination and nephron counting. Two
additional pregnant females of the control group were
given a subcutaneous injection of 20 mg/kg of retinoic acid
in peanut oil, on day 11 of gestation. The number of
nephrons was determined in four 14-day-old pups of each
litter and compared to the nephron number present in pups
born to two other control mothers injected with peanut oil.
Control and VAD females were also used for in vitro
experiments using metanephric organ culture. Six pregnant
females of each group were anesthetized on day 14 of
gestation, fetuses were aseptically removed and meta-
nephroi collected for culture. After six days of culture in
the presence or absence of retinoic acid, they were pre-
pared either for glomerular labeling and protein assay, or
for analysis of c-ret expression.
Metanephric organ culture
Metanephric organ culture was performed as previously
described [21, 22]. Briefly, the metanephroi explanted from
14-day-old fetuses were placed onto a 0.8 mm polycarbon-
ate filter (Millipore, Saint-Quentin-en-Yvelines, France),
floating on a defined serum-free medium and incubated for
six days in 35 mm Petri dishes at 37 6 0.5°C in a humidified
incubator with 5% CO2. Defined medium was DMEM/
Ham’s F12 (vol/vol) supplemented with HEPES (15 mM),
sodium bicarbonate (45 mM, pH 7.45), transferrin (6.2 3
1028 M), selenium (6.8 3 1029 M), insulin (8.3 3 1027 M),
triiodothyronine (2 3 1029 M) and prostaglandin E1 (7 3
1028 M). All reagents were purchased from Sigma (Saint-
Quentin-Fallavier, France). This medium is well suited for
metanephros differentiation [22].
A stock solution of all-trans-retinoic acid 10 mM was
prepared in absolute ethanol and stored at 220°C in the
dark. It was used in the culture medium at a 100 nanomolar
concentration. For each fetus, one kidney was grown in
control medium, and the other in the retinoic acid supple-
mented medium.
Nephron mass determination in the entire kidney
The number of nephrons was determined in kidneys of
21-day-old fetuses and 14-day-old pups by the method of
Damadian, Shawayri and Bricker [23] adapted for imma-
ture kidneys [24]. Whole kidneys were incubated in 50%
hydrochloric acid for 10 to 50 minutes at 37°C, the incuba-
tion time being dependent on the kidney weight. Kidneys
were rinsed with tap water and stored overnight at 4°C in a
gauged flask. Following mechanical dissociation, tubules
and glomeruli were suspended in water. Three aliquots of
known volume were used for counting the glomeruli by
three investigators unaware of the specimen origin.
Nephron counting and growth assessment in
metanephric organ culture
Nephrons formed in vitro can be counted after labeling of
all the glomeruli present in the explanted metanephroi
after six days of culture, using specific lectin-binding sites
located on the external membranes of the podocytes as
described previously [25]. Briefly, after fixation with 2%
paraformaldehyde in PBS, the explanted metanephroi were
detached from the filter, permeabilized with saponin, and
labeled with rhodamin-coupled peanut agglutinin. Count-
ing was performed independently by two investigators using
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an Optiphot microscope (Nikon, Champigny, France). Af-
ter counting, growth of the explanted metanephroi was
determined by their protein content. The labeled meta-
nephroi were rinsed in distilled water and sonicated for 15
seconds in individual tubes containing 0.5 ml of distilled
water. Protein content was measured in duplicate, accord-
ing to Lowry et al’s procedure [26] modified by Larson,
Howlett and Jagendorf [27], using bovine serum albumin as
standard.
Reverse-transcriptase polymerase chain reaction analysis
c-ret expression was analyzed in metanephroi from 15-
day-old embryos exposed in utero to VAD or to normal
vitamin A status, and also in metanephroi taken from
14-day-old control embryos and grown for six days under
paired conditions, that is, in the presence or absence of
retinoic acid (100 nM). Messenger RNAs were extracted
and pooled from at least eight metanephroi, using Dyna-
beads mRNA purification kit (Dynal, Oslo, Norway). Fol-
lowing reverse-transcription according to Kinoshita et al
[28], amplification for c-ret was performed based on the
nucleotide sequence Genbank X67812, using the following
primers: (S), 59-GCGCCCCGAGTG TGAGGAAT-
GTGG-39, and (AS), 59GCTGATGCAATGGGCGGCT-
TGTGC-39, leading to a PCR product size of 442 bp.
Primers for b-actin were used as an internal control to
normalize for c-ret expression and were: (S), 59-AA-
GAGAGGCATCCTGACCCT-39, and (AS), 59-GGC-
CATCTCTTGCTCGAAGT-39, with a predicted product
size of 504 bp. The reaction mixture was subjected to 30
cycles of amplification in a thermal cycler (Appligene
Oncor, Illkirch, France) using 200 mM of each dNTP and
0.75 U Pro-HA DNA polymerase (Eurogentec, Seraing,
Belgium). Each cycle consisted of a heat-denaturation step
at 95°C for one minute, annealing of primers at 63°C for
one minute, and polymerization at 72°C for one minute. To
perform relative quantification of gene expression as pro-
posed by Kinoshita et al [28], c-ret and b-actin mRNAs
were amplified as follows: first, primers for c-ret mRNA
sequence were added to the reaction mixture; then after 5
cycles of amplification, primers for b-actin were added for
25 additional cycles. The PCR products were visualized by
UV transillumination and photographed using 667 Po-
laroid films. Bands densitometry was performed using
image analysis software (NIH Image).
Plasma retinol determination
Plasma vitamin A concentration was determined by
reversed phase HPLC [29]. Briefly, samples were mixed
with an ethanol-solution. Two milliliters of n-hexane/buty-
lated hydroxytoluene were added for vitamin A extraction,
and the n-hexane phase was removed by evaporation under
nitrogen. The residue was dissolved in 200 ml of the mobile
phase methanol/dichloromethane 65/35, and 150 ml were
injected into a HPLC pump (Waters, Saint-Quentin en
Yvelines, France) linked to a multiwave length detector.
Detection was performed at 325 nm at a flow rate of 2
ml/min. Separation was performed on a nucleosil C-18
column with a precolumn module (Life Science Interna-
tional, Cergy Pontoise, France). Retinol was used as exter-
nal standard and retinol laurate as internal standard. All
reagents were of ultrapure grade (Sigma, Saint-Quentin-
Fallavier, France).
Statistics
All values are expressed as means 6 SEM. Control and
VAD data were compared by Mann-Whitney U-test. The
Wilcoxon’s test was used for comparison of paired in vitro
data. Significance was determined by P , 0.05. The rela-
tionship between two parameters was calculated by deter-
mining Pearson’s correlation coefficient.
RESULTS
In vivo experiments
The body growth of VAD and control females before
mating were similar (112 6 5 g weight gain vs. 109 6 8 g,
N 5 5 and 6, respectively). Fertility rates were 88 and
87.5%, respectively. Maternal growth during pregnancy was
regular in both groups, resulting in a similar weight gain
(172 6 10 g, N 5 5, vs. 170 6 15 g, N 5 6, respectively).
Plasma retinol concentration measured on day 21 of ges-
tation was decreased by approximately 50% in VAD fe-
males (14.6 6 1.1 mg/dl, N 5 5) as compared to controls
(30.5 6 2.8 mg/dl, N 5 6, P , 0.001).
The same number of fetuses was found in VAD and
control mothers (11.9 6 0.6 and 12.8 6 0.7, respectively).
No obvious developmental defect was observed in any of
the 21-day-old fetuses from either group. Plasma retinol
concentration in the fetus correlated to that of the mother
(Fig. 1). As reported in Table 1, plasma retinol concentra-
tion in the VAD fetuses was reduced by about 50% on
average. There was no delay in body or kidney growth.
However, the mean number of nephrons was reduced by
20%. When VAD and control data were plotted together,
the number of nephrons significantly correlated to plasma
retinol (Fig. 2). It also correlated for each group taken
separately (r 5 0.54, N 5 20, P , 0.05, for the VAD group;
r 5 0.51, N 5 24, P , 0.01, for controls). In VAD females
allowed to deliver spontaneously, the duration of preg-
nancy was normal. As shown in Table 2, the mean birth
weight of pups born to VAD mothers did not differ
significantly from that of pups born to control mothers. The
same held true for body wt on day 7 after birth, that is three
to four days after nephron induction was completed [30].
The final number of nephrons counted in 14-day-old pups
was reduced by 20%, that is, in the same proportion as the
number counted in 21-day-old fetuses. Pups, already defi-
cient in vitamin A at birth and breast fed by mothers
maintained on a VAD diet, had a very low plasma retinol
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concentration (4.2 6 0.8 mg/dl) compared with pups of the
control group (26.0 6 1.9 mg/dl). As expected, they, had
reduced body and kidney weights.
Pups born to mothers injected with retinoic acid on day
11 of gestation appeared normal at birth. As shown in
Table 3, the mean birth weight was similar to that of control
pups. Body and kidney weights on postnatal day 14 were
lower. However, the mean number of nephrons was in-
creased by 21% compared to controls.
In vitro experiments
At the time of fetal kidney collection (embryonic day 14),
the maternal plasma retinol concentration was about 50%
lower in VAD females (12.2 6 2.2 mg/dl, N 5 6) than in
control females (26.0 6 0.6; N 5 6, P , 0.001). The mean
body wt of embryos issued from both groups did not differ.
Metanephroi explanted from VAD embryos and cultured
in vitro for six days are shown on the Figure 3 and the
quantification of growth and differentiation parameters on
Figure 4. Despite identical culture conditions, the mean
protein content of metanephroi was decreased by 40%, and
the mean glomerular number by 30%. It is worthwhile to
note that the lower the maternal plasma retinol concentra-
tion, the fewer the nephrons formed in vitro (r 5 0.883, N 5
8, P , 0.001). In the presence of 100 nM of retinoic acid in
the culture medium, the metanephric growth and differen-
tiation were markedly stimulated in both groups, but
proportionally more for the metanephroi explanted from
Fig. 1. Fetal plasma retinol as a function of maternal plasma retinol at
21 days of gestation in control (F) and vitamin A deficiency (VAD; E)
groups. Means 6 SEM per litter: r 5 0.862, P , 0.001.
Table 1. Plasma retinol, body and kidney weights and number of














Control 24.0 5.27 26.0 5,621
N 5 24 6 0.8 6 0.09 6 0.9 6 86
VAD 12.9a 5.14 27.9 4,511a
N 5 20 6 1.2 6 0.08 6 0.5 6 124
Values are means 6 SEM.
a P , 0.001 vs control
Fig. 2. Number of glomeruli as a function of fetal plasma retinol in
21-day-old fetuses in control (F) and vitamin A deficiency (VAD; E)
groups: r 5 0.829, N 5 44, P < 0.001.
Table 2. Body weights at birth, at 7 days and at 14 days, and kidney
weights and number of glomeruli in 14-day-old fetuses issued from
control and vitamin A deficient (VAD) mothers
Groups
Body weight g 14 day kidney
weight mg
14 day number
of glomeruliBirth 7 days 14 days
Control 5.77 16.1 30.2 198 34,249
N 5 32 6 0.08 6 0.7 6 0.4 6 5 6 407
VAD 6.02 14.7 22.7a 146a 27,338a
N 5 32 6 0.05 6 1.0 6 0.4 6 4 6 630
Values are means 6 SEM.
a P , 0.001 vs. control
Table 3. Body weights at birth and at 14 days, kidney weights and
number of glomeruli in 14-day-old pups born to control and to mothers
injected with retinoic acid (RA) on day 11 of gestation
Groups
Body weight g 14 day kidney
weight mg
14 day number
of glomeruliBirth 14 days
Control 5.93 31.4 207 35,911
N 5 8 6 0.08 6 2.5 6 18 6 1,935
RA 6.05 21.2a 164a 43,322a
N 5 8 6 0.13 6 1.6 6 6 6 1,837
Values are means 6 SEM.
a P , 0.001 vs. control
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VAD embryos than for those explanted from control
embryos (79 6 9 vs. 42 6 10% for protein content, and
361 6 31 vs. 227 6 15% for glomerular number).
c-ret mRNA expression
As shown in Figure 5A, the c-ret mRNA level was
decreased by about 30% in metanephroi from 15-day-old
embryos from VAD females as compared to controls. c-ret
expression in in vitro experiments from 14-day-old embry-
onic rats is depicted in Figure 5B. The presence of retinoic
acid 100 nM in the culture medium for six days induced a
sevenfold increase in c-ret mRNAs.
DISCUSSION
The present study demonstrates for the first time that
mild vitamin A deficiency during gestation alters nephro-
genesis and results in a permanent nephron deficit. Prior to
this study, only severe vitamin A deficiencies or excess of
vitamin A have been considered as a risk factor for the
fetus. The present study also demonstrates that nephron
number in the fetus is linearly correlated with circulating
vitamin A levels. The correlation was found even for
animals in the control group.
In previous animal studies, severe vitamin A deficiency
during gestation resulted in multiple malformations in the
Fig. 3. Metanephros development in vitro assessed by lectin histochem-
istry. Explanted metanephroi from E14 embryos from control (A) or from
vitamin A deficiency (VAD; B) groups were grown for six days in a defined
medium. Bar represents 200 mm.
Fig. 4. In vitro development of control and vitamin A deficient (VAD)
metanephroi. Explanted metanephroi from embryonic day 14 (E14)
embryos from control or VAD females were grown for six days in a
defined medium in the presence or absence of 100 nM retinoic acid (RA).
(A) Growth was assayed by total protein content determination. (B)
Differentiation was analyzed by counting the total number of glomeruli
present within the metanephroi. #P , 0.001 as compared to paired
controlateral metanephros. *P , 0.001, as compared to the control group.
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fetus, with fetal growth retardation or death [13, 14]. In
these studies, the animals had been placed for two or three
months before mating, onto a diet containing enough
carotene for growth but not for appreciable storage of
vitamin A. They were then transferred onto a diet com-
pletely free of carotene and vitamin A, which was main-
tained throughout pregnancy. Since hepatic stores of vita-
min A take seven to eight weeks to be entirely consumed
[31], circulating vitamin A in the mother and in the fetus,
although not determined, was likely to be undetectable
within a few days, thus explaining the severe developmental
defects that were observed. Our goal, by contrast, was to
achieve a moderate decrease in circulating vitamin A to
determine whether it would influence renal development
without leading to either prenatal fatalities or global
growth retardation. We therefore deprived female rats
from vitamin A for a total of only six weeks, including the
duration of gestation, in order to avoid hepatic store
exhaustion. This led to about a two times reduction of
plasma vitamin A at term, and even two weeks after birth,
plasma vitamin A levels, although very low, were still
measurable in pups born to VAD mothers.
Vitamin A is transported from the mother to the fetus
bound to retinol binding protein [32]. In the present study,
fetal plasma retinol variations followed maternal plasma
retinol variations. However, the mean plasma retinol con-
centration in the fetus was about 15% lower than that in the
mother. Of interest is the fact that the difference between
maternal and fetal plasma retinol was reported to be
higher, around 50%, during normal human pregnancy. This
may partly explain why the frequency of inadequate vitamin
A levels was found to be higher in fetuses than in their
mothers [15, 33].
Pups born to VAD mothers had a reduced number of
nephrons. This number is clearly inappropriate for a birth
body weight as compared to controls. In pups maintained
with VAD mothers during lactation, the body weight was,
as expected, found to be reduced on day 14, leading to a
number of nephrons per body weight ratio similar to that of
control pups. However, as observed in littermates weaned
on standard diet, total catch-up of growth retardation
occurred within two weeks (body wt on day 14 after birth,
30.1 6 0.9 vs. 29.7 6 1.3 g in control and VAD rats
respectively, N 5 32 in each group). These pups will
therefore have an inappropriate number of nephrons for
their body weight.
A permanent nephron deficit has been found in humans
and animals with intra-uterine growth retardation [34–37].
In the present study, however, pups born to VAD mothers
had impaired nephrogenesis, but normal birth weights.
Fetal growth retardation is often related to placental blood
flow disturbances. We therefore suggest that nephron
deficit of growth retardation results from a low vitamin A
supply to the fetus. It has indeed been reported that
vitamin A and retinol binding protein plasma concentra-
tions, and liver stores of vitamin A are low in growth
retarded newborn infants [38, 39].
The complete spectrum of congenital abnormalities in
severe vitamin A deficiency is also present in double
mutant mice for specific combinations of retinoic acid
nuclear receptors [40, 41]. Thus, the developmental defects
following severe vitamin A deficiency is likely to result from
reduced retinoic acid content. Retinoic acid may also be
involved in renal phenotype of mild vitamin A deficiency,
since we found that a single injection of retinoic acid to the
mother was able to increase nephrogenesis in the fetus. It is
also suggested that the content of endogenous retinoic acid
was diminished in the metanephroi of vitamin A deficient
fetuses that developed in vitro to a lower extent. However,
the capacity of these metanephroi to respond to exogenous
retinoic acid was not altered. These data are consistent with
our previous data reporting that retinoic acid controlled the
number of nephrons formed in metanephric organ culture
in a dose dependent manner [16].
Nephron formation in the metanephric mesenchyme is
induced by the tips of the growing branches of the ureteric
bud [42]. As a consequence, nephron number depends on
the branching capacity of the ureteric bud. We previously
reported that retinoic acid stimulates in vitro nephrogenesis
through an effect on the ureteric bud branching morpho-
genesis [16]. Consistently, nephron deficits were found in
the present study to be proportionally the same in 21-day-
old fetuses and in 14-day-old pups, which can be explained
by the fact that the ureteric bud no longer branches during
late nephrogenesis [43]. No additional deficit could thus be
Fig. 5. Product analysis of RT-PCR for c-ret mRNA. (A) Metanephroi
from 15-day-old embryos from control and VAD females. (B) Pairs of
metanephroi from 14-day-old embryos from control females cultured for
six days in the presence or absence of 100 nM retinoic acid. Two percent
agarose gel stained with ethidium bromide revealed the c-ret (442 bp) and
the b actin control (504 bp) bands. Blots are representative of experiments
repeated five times (A) and three times (B). The amount of mRNA in the
different experimental groups was quantified by scanning densitometry
and expressed as percent of control.
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induced by vitamin A deficiency. We therefore propose that
retinoic acid controls branching morphogenesis of the
ureteric bud in vivo as it does in vitro.
From a molecular point of view, one likely candidate to
mediate the vitamin A-dependent renal organogenesis is
the ret protooncogene, as already proposed [16]. It has
been reported that its product, a receptor tyrosine kinase, is
expressed in the metanephros and is restricted to the tips of
the ureteric bud [44]. The role of c-ret in kidney formation
is crucial, since null mice for this gene exhibit renal agenesis
or have rudimentary kidneys due to failure of the ureteric
bud to develop [17]. In the present study we found that
c-ret expression was modulated according to the retinoid
environment. This is consistent with previous report show-
ing that c-ret expression can be induced during neuronal
differentiation upon retinoic acid exposure [45]. Thus far,
no retinoic acid response element has been found within
the c-ret promoter [46]. However, retinoic acid nuclear
receptors (RAR) are likely to control the c-ret expression
that we observed, since renal agenesis or hypoplasia were
found in both c-ret null mice and RAR double mutant mice
[17, 40].
Finally, our results demonstrate that fetal nephron num-
ber strictly correlates to the vitamin A circulating level.
This highlights the fact that nephron number is highly
dependent on both the placental blood flow and the vitamin
A status of the mother. This finding may explain the large
variation in the number of nephrons found in otherwise
healthy human populations [36, 47–49]. Due to alimentary
habits, inadequate intakes of vitamin A may be a common
feature, even in developed countries, and in some women
the resulting low vitamin A stores may not be sufficient to
meet increased demands during pregnancy [7, 8, 15, 50, 51].
A relatively large population of apparently normal new-
borns may therefore have had altered nephrogenesis, lead-
ing to permanent nephron deficit with possible long-term
clinical consequences.
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